Clinical Trial Update: Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot [Phase 2]

View source ↗

Summary

A Phase 2 HALO pilot study evaluated unfractionated heparin anticoagulation as a potential adjunct therapy in septic shock; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: University of Manitoba | Conditions: Septic Shock | Phase 2 | Status: COMPLETED